Senti Biosciences
SNTI----
Senti Biosciences (SNTI)
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologie...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Senti Biosciences Analyst Rating
View MoreForecast & Rating
Jul 16, 2026Price forecast
$13.003119.42%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jul 16 at 12:05 PM
12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga_article · Jul 15 at 12:05 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
- PUBT · Jul 15 at 06:31 AM
Senti Biosciences to spin off SENTI-202 assets to Celadon-backed NewCo for CVR worth up to $60 million
- Tip Ranks · May 16 at 01:00 AM
Senti Biosciences Faces Severe Refinancing and Liquidity Risks from Costly Note Structure
- Earnings Watch · May 14 at 03:30 PM
Senti Biosciences | 10-Q: FY2026 Q1 Revenue: USD 16 K
- StockTitan · May 13 at 11:45 PM
Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase | SNTI Stock News
